Data for (Study ST001982)
(Analysis AN003232)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this study| Metabolite | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 | F19 | F20 | F21 | F22 |
|---|
Factors:
| F1 | Treatment:AbA-treated | Concentration (ug/ml):0.5 | Extraction method:Phospholipids | Ionization mode:Negative |
| F2 | Treatment:AbA-treated | Concentration (ug/ml):0.5 | Extraction method:Phospholipids | Ionization mode:Positive |
| F3 | Treatment:AbA-treated | Concentration (ug/ml):0.5 | Extraction method:Sphingolipids | Ionization mode:Negative |
| F4 | Treatment:AbA-treated | Concentration (ug/ml):0.5 | Extraction method:Sphingolipids | Ionization mode:Positive |
| F5 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:phospholipids | Ionization mode:Negative |
| F6 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:Phospholipids | Ionization mode:Negative |
| F7 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:phospholipids | Ionization mode:Positive |
| F8 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:Phospholipids | Ionization mode:Positive |
| F9 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:Sphingolipids | Ionization mode:Negative |
| F10 | Treatment:AbA-treated | Concentration (ug/ml):1 | Extraction method:Sphingolipids | Ionization mode:Positive |
| F11 | Treatment:AbA-treated | Concentration (ug/ml):2 | Extraction method:Phospholipids | Ionization mode:Negative |
| F12 | Treatment:AbA-treated | Concentration (ug/ml):2 | Extraction method:Phospholipids | Ionization mode:Positive |
| F13 | Treatment:AbA-treated | Concentration (ug/ml):2 | Extraction method:Sphingolipids | Ionization mode:Negative |
| F14 | Treatment:AbA-treated | Concentration (ug/ml):2 | Extraction method:Sphingolipids | Ionization mode:Positive |
| F15 | Treatment:AbA-treated | Concentration (ug/ml):4 | Extraction method:Phospholipids | Ionization mode:Negative |
| F16 | Treatment:AbA-treated | Concentration (ug/ml):4 | Extraction method:Phospholipids | Ionization mode:Positive |
| F17 | Treatment:AbA-treated | Concentration (ug/ml):4 | Extraction method:Sphingolipids | Ionization mode:Negative |
| F18 | Treatment:AbA-treated | Concentration (ug/ml):4 | Extraction method:Sphingolipids | Ionization mode:Positive |
| F19 | Treatment:Control | Concentration (ug/ml):- | Extraction method:Phospholipids | Ionization mode:Negative |
| F20 | Treatment:Control | Concentration (ug/ml):- | Extraction method:Phospholipids | Ionization mode:Positive |
| F21 | Treatment:Control | Concentration (ug/ml):- | Extraction method:Sphingolipids | Ionization mode:Negative |
| F22 | Treatment:Control | Concentration (ug/ml):- | Extraction method:Sphingolipids | Ionization mode:Positive |
